XERS
NASDAQ · Pharmaceuticals
Xeris Biopharma Holdings Inc
$7.93
+0.57 (+7.74%)
Open$7.43
Previous Close$7.36
Day High$8.02
Day Low$7.43
52W High$10.08
52W Low$5.25
Volume—
Avg Volume1.59M
Market Cap1.27B
P/E Ratio105.82
EPS$0.06
SectorPharmaceuticals
Analyst Ratings
Strong Buy
13 analysts
Price Target
+488.3% upside
Current
$7.93
$7.93
Target
$46.65
$46.65
$35.62
$46.65 avg
$60.75
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 265.69M | 192.04M | 186.74M |
| Net Income | 503.2K | 327.4K | 58.69M |
| Profit Margin | 0.2% | 0.2% | 31.4% |
| EBITDA | 32.54M | 22.34M | 67.69M |
| Free Cash Flow | — | — | 40.84M |
| Rev Growth | +38.4% | +38.4% | +1.9% |
| Debt/Equity | 16.10 | 16.10 | 0.60 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,185.71 | -0.52% | 41.4 | 1.11T |
| JNJ | Johnson & Johnson | $259.24 | +0.88% | 29.3 | 617.08B |
| MRK | Merck & Co. Inc. | $128.58 | +0.16% | 99.4 | 315.27B |
| PFE | Pfizer Inc. | $26.76 | +2.14% | 34.8 | 150.87B |
| BMY | Bristol-Myers Squibb Co | $64.72 | +0.89% | 14.1 | 131.10B |
| ZTS | Zoetis Inc | $72.66 | -5.97% | 12.3 | 32.39B |